Curis director granted options on 6,800 shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
CURIS INC director Martyn D. Greenacre received a grant of options on 6,800 shares of common stock. These non-qualified stock options have an exercise price of $5.29 per share and expire on July 6, 2036. The options vest 100% on July 7, 2027, aligning compensation with longer-term performance.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Non Qualified Stock Option | 6,800 | $5.29 | $36K |
Footnotes (1)
- F1. The option grant described in this Form 4 filing vests as to 100% of the underlying shares on July 7, 2027.
Key Figures
Key Terms
Non Qualified Stock Option financial
exercise price financial
expiration date financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did CURIS INC (CRIS) director Martyn D. Greenacre report on this Form 4?
What are the key terms of Martyn D. Greenacre’s 6,800 CURIS INC stock options?
When do Martyn D. Greenacre’s CURIS INC options vest according to the Form 4?
How many CURIS INC options does Martyn D. Greenacre hold after this grant?
What does the $5.29 exercise price mean for the CURIS INC option grant?
AI-generated analysis. How Rhea-AI works. Not financial advice.